Tolerion Inc. - Targeting Autoimmune Diseases

TOL-3021 Phase 2a clinical trial press release. Portola Valley, CA 94028. Tolerions lead product, TOL-3021, is a novel reverse vaccine that induces tolerance to the type 1 diabetes specific autoantigen proinsulin and thereby reduces disease activity. Results from a phase 2a study demonstrate that TOL-3021. Is safe and preserves beta-cell function while reducing. Disease-specific destructive T-cell activity in patients. With type 1 diabetes. These findings were. Recently published in the journal.

OVERVIEW

The web site tolerioninc.com currently has an average traffic classification of zero (the smaller the more users). We have traversed one page inside the site tolerioninc.com and found zero websites linking to tolerioninc.com. There are one contacts and directions for tolerioninc.com to help you correspond with them. The web site tolerioninc.com has been on the internet for five hundred and seventy-six weeks, fifteen days, nine hours, and forty-six minutes.
Pages Parsed
1
Contacts
1
Addresses
1
Online Since
Jun 2013

TOLERIONINC.COM TRAFFIC

The web site tolerioninc.com has seen alternating amounts of traffic until the end of the year.
Traffic for tolerioninc.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for tolerioninc.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for tolerioninc.com

Date Range

All time
This Year
Last Year
Last Month

TOLERIONINC.COM HISTORY

The web site tolerioninc.com was created on June 22, 2013. This site will go back on the market on the date of June 21, 2018. It is currently five hundred and seventy-six weeks, fifteen days, nine hours, and forty-six minutes young.
REGISTERED
June
2013
EXPIRED
June
2018

SPAN

11
YEARS
0
MONTHS
15
DAYS

LINKS TO WEBSITE

WHAT DOES TOLERIONINC.COM LOOK LIKE?

Desktop Screenshot of tolerioninc.com Mobile Screenshot of tolerioninc.com Tablet Screenshot of tolerioninc.com

CONTACTS

Nigel Ray

321 Dedalera Dr

Portola Valley, California, 94028

United States

TOLERIONINC.COM SERVER

Our crawlers detected that a single root page on tolerioninc.com took two hundred and thirty-four milliseconds to stream. Our web crawlers could not discover a SSL certificate, so in conclusion I consider this site not secure.
Load time
0.234 sec
SSL
NOT SECURE
IP
50.62.217.1

NAME SERVERS

ns51.domaincontrol.com
ns52.domaincontrol.com

SERVER SOFTWARE AND ENCODING

We found that this website is using the Apache os.

SITE TITLE

Tolerion Inc. - Targeting Autoimmune Diseases

DESCRIPTION

TOL-3021 Phase 2a clinical trial press release. Portola Valley, CA 94028. Tolerions lead product, TOL-3021, is a novel reverse vaccine that induces tolerance to the type 1 diabetes specific autoantigen proinsulin and thereby reduces disease activity. Results from a phase 2a study demonstrate that TOL-3021. Is safe and preserves beta-cell function while reducing. Disease-specific destructive T-cell activity in patients. With type 1 diabetes. These findings were. Recently published in the journal.

PARSED CONTENT

The web site tolerioninc.com has the following in the site, "TOL-3021 Phase 2a clinical trial press release." I saw that the website also stated " Portola Valley, CA 94028." They also said " Tolerions lead product, TOL-3021, is a novel reverse vaccine that induces tolerance to the type 1 diabetes specific autoantigen proinsulin and thereby reduces disease activity. Results from a phase 2a study demonstrate that TOL-3021. Is safe and preserves beta-cell function while reducing. Disease-specific destructive T-cell activity in patients. Recently published in the journal." The meta header had Tolerance as the first optimized keyword. This keyword is followed by DNA vaccine, DNA vaccination, and DNA immunization which isn't as important as Tolerance. The other words tolerioninc.com used was autoimmunity. autoimmune is included but might not be understood by web engines.

ANALYZE SIMILAR WEBSITES

My CMS Αρχική

Ship in stormy waters wordpress theme. Το λάδι της ζωής μας. Σας καλωσορίζουμε στον επίσημο δικτυακό τόπο της εταιρείας μας! Το ελαιόλαδο που διακινεί το Λιοστάσι, παράγεται από ελαιώνες που καλλιεργούνται με σύγχρονες μεθόδους. Στις εγκαταστάσεις μας τυποποιείται το ελαιόλαδο που παράγεται από την σοδειά της περιοχής μας. Στόχος της εταιρίας μας είναι η δημιουργία προιόντων με ταυτότητα, που απευθύνονται στον σύγχρονο καταναλωτή.

Tolerisk Risk Tolerance Assessment Tool for Advisors

Investment Risk Tolerance Assessment tool for Advisors to better serve their clients. The leading Investment Risk Tolerance Assessment tool for Advisors to better serve their clients. The Science of Risk Tolerance. See how it benefits your practice and your clients. Clients are generally slotted in one of three to fiv.

Toler Leadership International

This website is dedicated to the resourcing and training of leaders worldwide. TLI is a 501c3 non-proft organization founded in 1993 for the sole purpose of leadership development. Toler Leadership International is led by its founder Dr. Stan Toler who is a bestselling author and leadership expert. Over one million leaders have been trained through his corporate, non-profit and church related seminars.

Toler Network

Search Engine Marketing lets your advertisements show to customers when they search corresponded keywords in search engine. Usually, SEM is used exclusively to mean pay per click advertising. We would recommend you the most appropriate and effective mobile ad formats and targeting options to achieve your objectives and leverage your ROI in the rapidly changing environment of mobile marketing.

Tolero Cups

NEW ON THE MARKET! We are glad to present to our customers a new product - vending cup. Vending cups are getting more and more fashionable nowadays, replacing slowly but surely the plastic vending cups. Tolero 06 LTD offers its propecia online. Customers to take advantage of the future trends in the paper packaging. We offer paper celebrity porn. Cups, paper plates, paper trays and hamburger boxes all made of ECO Paper and Cartons.